Fluoxetine for Visual Recovery After Ischemic Stroke

Trial Profile

Fluoxetine for Visual Recovery After Ischemic Stroke

Recruiting
Phase of Trial: Phase II

Latest Information Update: 20 Jul 2017

At a glance

  • Drugs Fluoxetine (Primary)
  • Indications Vision disorders
  • Focus Therapeutic Use
  • Acronyms FLUORESCE
  • Most Recent Events

    • 16 Jul 2017 Planned primary completion date changed from 1 Jun 2017 to 1 Jun 2020.
    • 25 Oct 2016 Status changed from not yet recruiting to recruiting.
    • 19 Apr 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top